From your description of tolerance buildup it sounds like you are describing a drug which is functionally ineffective for chronic pain (eventually tolerance will overtake the maximum does you can safely administer) except where the patient wont live long enough for the tolerance.
It sounds like a drug family that would be mostly useful for non-chronic pain, where the patient can be weaned off before the dosages become high.
Yet its usage is the opposite?